Lv1
50 积分 2025-03-11 加入
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
7天前
已完结
ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall – Endorsed by ASTRO
26天前
已关闭
Chinese expert consensus on endocrine therapy for breast cancer (2026 edition)
27天前
已关闭
ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I–III small cell lung cancer
1个月前
已完结
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline
3个月前
已完结
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
3个月前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
3个月前
已关闭
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3个月前
已完结
Olaparib outcomes in metastatic castration-resistant prostate cancer: First real-world experience in safety and efficacy from the Chinese mainland
4个月前
已完结
Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix
5个月前
已关闭
皖公网安备34019202002308
